home | refresh Medical Pearls from the Internet Medical Association

For diabetics hospitalized with COVID-19, the addition of the DPP-4 inhibitor sitagliptin to insulin was associated with improved clinical outcomes. Comment: This study raises the possibility that the addition of sitagliptin to the routine hospital care in Italy (insulin only with outpatient PO meds stopped) is beneficial to a wider range of patients. Might this also be of benefit in community acquired pneumonias? Diabetes Care . 2020 Sep 29;dc201521.    (retrieved Oct, 2020). There are currently 1090 pearls in the database. While every attempt has been made to ensure accuracy, mistakes can and do occur. Use databank at your own risk. All pearls © 2024 by the Internet Medical Association. Click Here to view more medical pearls.